blastocystis การใช้

• Four common forms of " Blastocystis hominis ".
• These cells were absent in " Blastocystis " cultures from healthy controls.
• There are conflicting reports regarding whether " Blastocystis " causes disease in humans.
• Regional and temporal variations in those illnesses follow those associated with infection with the protozoan Blastocystis.
• "Blastocystis " is a single-celled protozoan which infects the large intestine.
• This method also allows the species group of " Blastocystis " to be identified.
• "Blastocystis " spp . prevalence in humans often exceeds 5 % in industrialized countries.
• A number of researchers have investigated the possibility that some species of Blastocystis are more virulent than others.
• The development of a classification system for Blastocystis in 2007 produced a series of studies investigating this possibility.
• Miconazole and quinacrine have been reported as effective agents against " Blastocystis " growth in-vitro.
• Because of this, in 2007 scientists proposed discontinuing the use of the term " Blastocystis hominis ."
• "Blastocystis " is one of the most common human parasites in the world and has a global distribution.
• The studies that followed generally found that there is no specific " pathogenic " or non-pathogenic species of Blastocystis.
• Physicians have described the successful use of a variety of discontinued antiprotozoals in treatment of " Blastocystis " infection.
• One study found that 43 % of IBS patients were infected with " Blastocystis " versus 7 % of controls.
• This method has been reported to be more reliable at detecting " Blastocystis " in symptomatic patients than stool culture.
• Subsequent genetic analysis showed the " Blastocystis " from healthy controls was genetically distinct from that found in patients with symptoms.
• Rifaximin, and albendazole have shown promise as has ivermectin which demonstrated high effectiveness against blastocystis hominis isolates in an in vitro study.
• Like other protozoal infections, the prevalence of " Blastocystis " infection varies depending on the area investigated and the population selected.
• There is also evidence that the probiotic yeast " Saccharomyces boulardii ", may be effective against " Blastocystis " infections.